These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 9761057)
1. Role of transforming growth factor-beta1 in the pathogenesis of moyamoya disease. Hojo M; Hoshimaru M; Miyamoto S; Taki W; Nagata I; Asahi M; Matsuura N; Ishizaki R; Kikuchi H; Hashimoto N J Neurosurg; 1998 Oct; 89(4):623-9. PubMed ID: 9761057 [TBL] [Abstract][Full Text] [Related]
2. Possible roles of basic fibroblast growth factor in the pathogenesis of moyamoya disease: an immunohistochemical study. Hoshimaru M; Takahashi JA; Kikuchi H; Nagata I; Hatanaka M J Neurosurg; 1991 Aug; 75(2):267-70. PubMed ID: 2072165 [TBL] [Abstract][Full Text] [Related]
3. Increased levels of circulating endothelial progenitor cells in patients with Moyamoya disease. Rafat N; Beck GCh; Peña-Tapia PG; Schmiedek P; Vajkoczy P Stroke; 2009 Feb; 40(2):432-8. PubMed ID: 19095988 [TBL] [Abstract][Full Text] [Related]
4. Development of intimal thickening in superficial temporal arteries in patients with moyamoya disease. Aoyagi M; Fukai N; Yamamoto M; Matsushima Y; Yamamoto K Clin Neurol Neurosurg; 1997 Oct; 99 Suppl 2():S213-7. PubMed ID: 9409440 [TBL] [Abstract][Full Text] [Related]
5. Increased expression of serum Matrix Metalloproteinase-9 in patients with moyamoya disease. Fujimura M; Watanabe M; Narisawa A; Shimizu H; Tominaga T Surg Neurol; 2009 Nov; 72(5):476-80; discussion 480. PubMed ID: 19147196 [TBL] [Abstract][Full Text] [Related]
6. Early development of intimal thickening in superficial temporal arteries in patients with moyamoya disease. Aoyagi M; Fukai N; Yamamoto M; Nakagawa K; Matsushima Y; Yamamoto K Stroke; 1996 Oct; 27(10):1750-4. PubMed ID: 8841323 [TBL] [Abstract][Full Text] [Related]
7. Expression of TGF-beta1 in smooth muscle cells regulates endothelial progenitor cells migration and differentiation. Zhu C; Ying D; Zhou D; Mi J; Zhang W; Chang Q; Li L J Surg Res; 2005 May; 125(2):151-6. PubMed ID: 15854667 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of cytokines in cerebrospinal fluid from patients with moyamoya disease. Yoshimoto T; Houkin K; Takahashi A; Abe H Clin Neurol Neurosurg; 1997 Oct; 99 Suppl 2():S218-20. PubMed ID: 9409441 [TBL] [Abstract][Full Text] [Related]
9. Altered cellular responses to serum mitogens, including platelet-derived growth factor, in cultured smooth muscle cells derived from arteries of patients with moyamoya disease. Aoyagi M; Fukai N; Sakamoto H; Shinkai T; Matsushima Y; Yamamoto M; Yamamoto K J Cell Physiol; 1991 May; 147(2):191-8. PubMed ID: 2040653 [TBL] [Abstract][Full Text] [Related]
10. Increased expression of hepatocyte growth factor in cerebrospinal fluid and intracranial artery in moyamoya disease. Nanba R; Kuroda S; Ishikawa T; Houkin K; Iwasaki Y Stroke; 2004 Dec; 35(12):2837-42. PubMed ID: 15528455 [TBL] [Abstract][Full Text] [Related]
11. Smooth muscle cell proliferation and localization of macrophages and T cells in the occlusive intracranial major arteries in moyamoya disease. Masuda J; Ogata J; Yutani C Stroke; 1993 Dec; 24(12):1960-7. PubMed ID: 7902623 [TBL] [Abstract][Full Text] [Related]
12. Increase in elastin gene expression and protein synthesis in arterial smooth muscle cells derived from patients with Moyamoya disease. Yamamoto M; Aoyagi M; Tajima S; Wachi H; Fukai N; Matsushima Y; Yamamoto K Stroke; 1997 Sep; 28(9):1733-8. PubMed ID: 9303017 [TBL] [Abstract][Full Text] [Related]
13. [Plasma fibronectin level in patients with moyamoya disease]. Sasaki O; Tanaka R; Koike T; Takeuchi S; Takizawa T; Ishi R; Arai H No To Shinkei; 1987 Nov; 39(11):1069-73. PubMed ID: 3442638 [TBL] [Abstract][Full Text] [Related]
14. [Concentrations of granulocyte colony-stimulating factor in children with moyamoya disease]. Ma MS; Zou LP; Ding YX; Jin H Zhongguo Dang Dai Er Ke Za Zhi; 2010 Feb; 12(2):117-9. PubMed ID: 20199726 [TBL] [Abstract][Full Text] [Related]
15. Regulation of transforming growth factor-beta1 expression by granulocyte macrophage-colony-stimulating factor in leiomyoma and myometrial smooth muscle cells. Chegini N; Tang XM; Ma C J Clin Endocrinol Metab; 1999 Nov; 84(11):4138-43. PubMed ID: 10566662 [TBL] [Abstract][Full Text] [Related]
16. Enhancement expression of bFGF in Chinese patients with Moyamoya disease. Zou D; Zhao J; Zhang D; Wang S; Wang K; Zhang Y Biomed Environ Sci; 2011 Feb; 24(1):74-80. PubMed ID: 21440843 [TBL] [Abstract][Full Text] [Related]
17. Human arterial smooth muscle cell strains derived from patients with moyamoya disease: changes in biological characteristics and proliferative response during cellular aging in vitro. Fukai N; Aoyagi M; Yamamoto M; Sakamoto H; Ogami K; Matsushima Y; Yamamoto K Mech Ageing Dev; 1994 Jul; 75(1):21-33. PubMed ID: 9128751 [TBL] [Abstract][Full Text] [Related]
18. Pathophysiology and genetic factors in moyamoya disease. Achrol AS; Guzman R; Lee M; Steinberg GK Neurosurg Focus; 2009 Apr; 26(4):E4. PubMed ID: 19335130 [TBL] [Abstract][Full Text] [Related]
19. Mediation of interleukin-1beta-induced transforming growth factor beta1 expression by activator protein 4 transcription factor in primary cultures of bovine articular chondrocytes: possible cooperation with activator protein 1. Andriamanalijaona R; Felisaz N; Kim SJ; King-Jones K; Lehmann M; Pujol JP; Boumediene K Arthritis Rheum; 2003 Jun; 48(6):1569-81. PubMed ID: 12794825 [TBL] [Abstract][Full Text] [Related]
20. Role of platelet-derived growth factor and transforming growth factor beta1 the in the regulation of metalloproteinase expressions. Borrelli V; di Marzo L; Sapienza P; Colasanti M; Moroni E; Cavallaro A Surgery; 2006 Sep; 140(3):454-63. PubMed ID: 16934609 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]